<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04025229</url>
  </required_header>
  <id_info>
    <org_study_id>LCCC 1839</org_study_id>
    <secondary_id>1R21CA235029-01</secondary_id>
    <nct_id>NCT04025229</nct_id>
  </id_info>
  <brief_title>High Intensity Interval Training in Endometrial Cancer</brief_title>
  <official_title>Pre-operative Window Study of Interval Exercise Training as a Therapy for Endometrial Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UNC Lineberger Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>UNC Lineberger Comprehensive Cancer Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This interventional trial recruits women with endometrial cancer to participate in high&#xD;
      intensity interval training (HIIT) prior to their standard of care surgery. The study will&#xD;
      evaluate tissue and blood to determine if HIIT training has anti-cancer effects. P&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Objectives:&#xD;
&#xD;
      1. Determine the anti-proliferative effect of HIIT on the endometrium of women with&#xD;
      endometrial cancer 2. Participants will undergo baseline testing, be taught how to perform&#xD;
      personalized HIIT training prior to surgery, and repeat testing after surgery. Tissue&#xD;
      specimens will be collected from standard of care biopsy (no extra biopsy needed) and during&#xD;
      surgery. Blood will be collected twice during standard of care blood draws.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2019</start_date>
  <completion_date type="Anticipated">May 20, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 20, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Participants will complete HIIT training prior to surgery</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in proliferative markers in endometrium before and after HIIT exercises</measure>
    <time_frame>3 years</time_frame>
    <description>Ki-67 values in biopsy samples</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Endometrial Cancer</condition>
  <arm_group>
    <arm_group_label>HIIT exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will perform HIIT exercises as instructed by the study team in the weeks prior to standard of care surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HIIT exercise</intervention_name>
    <description>High intensity interval training (4 to 6 sessions) prior to surgery</description>
    <arm_group_label>HIIT exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with a diagnosis of endometrial cancer who are to undergo hysterectomy and&#xD;
             staging&#xD;
&#xD;
          -  Between 40-75 years old&#xD;
&#xD;
          -  Body mass index of 30-50 kg/m2&#xD;
&#xD;
          -  Endometrioid histology endometrial cancer&#xD;
&#xD;
          -  Presumed clinically early stage disease (disease confined to uterus only)&#xD;
&#xD;
          -  Have access to a Smart Phone&#xD;
&#xD;
          -  Have access to email&#xD;
&#xD;
          -  Agree to visit the exercise and sport science laboratory within 2 days of SOC visit&#xD;
             for baseline testing if enrollment procedures cannot be done on the same day.&#xD;
&#xD;
        Agree to visit clinic 2 (+/-2wks) weeks after surgery for SOC follow-up and post surgery&#xD;
        visit, or willing to return to exercise and sport science laboratory 2 (+/-2wks) weeks&#xD;
        post-surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Meets American College of Sports Medicine Guidelines for physical activity (150&#xD;
             minutes / week)&#xD;
&#xD;
          -  Currently doing HIIT&#xD;
&#xD;
          -  Hospitalization for a stroke, heart attack, or heart failure, or had surgery for&#xD;
             blocked arteries in the past 3 months&#xD;
&#xD;
          -  Active diagnosis of psychosis or current uncontrolled substance abuse disorder&#xD;
&#xD;
          -  Insulin-dependent diabetes&#xD;
&#xD;
          -  Currently in another EC intervention&#xD;
&#xD;
          -  Severe dementia or other memory loss condition&#xD;
&#xD;
          -  Severe mental health disorder&#xD;
&#xD;
          -  Severely impaired hearing or speech&#xD;
&#xD;
          -  Inability to speak English&#xD;
&#xD;
          -  Musculoskeletal or neuromuscular condition that limits physical activity Any&#xD;
             condition, in the opinion of the investigators, which would prohibit safe&#xD;
             participation.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>This study recruits women with endometrial cancer</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victoria Bae-Jump, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luz Cuaboy</last_name>
    <phone>919-966-7051</phone>
    <email>luz_cuaboy@med.unc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Abbie Smith-Ryan, PhD</last_name>
    <phone>919-962-2574</phone>
    <email>abbsmith@email.unc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UNC Lineberger Comprehensive Cancer Center</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luz Cuaboy</last_name>
      <phone>919-966-7051</phone>
      <email>luz_cuaboy@med.unc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>July 16, 2019</study_first_submitted>
  <study_first_submitted_qc>July 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2019</study_first_posted>
  <last_update_submitted>May 28, 2021</last_update_submitted>
  <last_update_submitted_qc>May 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

